MonoSol Rx to Present at 2015 American Association of Pharmaceutical Scientists Annual Exposition Demonstrating PharmFilm as a Bioequivalent Delivery Platform for Sildenafil Citrate
21 oct. 2015 16h35 HE
|
MonoSol Rx
WARREN, N.J., Oct. 21, 2015 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to develop treatments that improve patient...
MonoSol Rx Leadership Presents Data Supporting PharmFilm Technology Effective for Oral Peptide Delivery
19 oct. 2015 16h15 HE
|
MonoSol Rx
WARREN, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to develop treatments that improve patient...
MonoSol Rx Partner Galena Biopharma Launches Zuplenz(R) (Ondanestron) Oral Soluble Film
05 août 2015 10h03 HE
|
MonoSol Rx
WARREN, N.J., Aug. 5, 2015 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to develop treatments that improve patient...
MonoSol Rx Announces Initiation of Phase 2a Trial for Oral Insulin Film
27 juil. 2015 15h01 HE
|
MonoSol Rx
Midaform® Insulin PharmFilm® delivers Insulin through Buccal Soluble Film
WARREN, N.J., July 27, 2015 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm drug delivery technology,...
MonoSol Rx Leadership Presented PharmFilm Buccal Delivery Clinical Update at Leading Pharmaceutical Technology Meeting
09 févr. 2015 08h00 HE
|
MonoSol Rx
WARREN, N.J., Feb. 9, 2015 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, presented the Company's technology recently at the International Association for...
MonoSol Rx Names A. Mark Schobel Chief Innovation & Technology Officer; Keith Kendall Assumes Role of CEO
17 déc. 2014 09h58 HE
|
MonoSol Rx
WARREN, N.J., Dec. 17, 2014 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced that Keith Kendall will assume the role of Chief Executive...
US Patent Office Institutes Inter Partes Review Brought by MonoSol Rx Against All Claims in Key BDSI BEMA Patent
06 oct. 2014 09h35 HE
|
MonoSol Rx
WARREN, N.J., Oct. 6, 2014 (GLOBE NEWSWIRE) -- The United States Patent and Trademark Office (USPTO) has granted MonoSol Rx, LLC's (MonoSol Rx) petition for inter partes review (IPR) of all claims of...
MonoSol Rx Launches Clinical Study of MSRX-110 Oral Film for Testosterone Replacement
18 août 2014 08h30 HE
|
MonoSol Rx
WARREN, N.J., Aug. 18, 2014 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced that it has begun enrolling patients with hypogonadism in an...
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma for Zuplenz(R) Oral Soluble Film
22 juil. 2014 07h15 HE
|
MonoSol Rx
WARREN, N.J., July 22, 2014 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced that it has licensed Zuplenz® (ondansetron) to Galena...
MonoSol Rx Appoints Joseph Crusco Director of Business Development
10 juil. 2014 08h30 HE
|
MonoSol Rx
WARREN, N.J., July 10, 2014 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced the appointment of Joseph Crusco to the position of Director,...